Leveraging Biosimulation to Inform Optimal Use of COVID-19 Vaccines

Feb 03, 2021

Certara’s SVP & Head of Quantitative Systems Pharmacology, Dr. Piet van der Graaf, discusses how biosimulation with Certara’s COVID-19 vaccine model can help optimize allocation of the world’s limited supplies of COVID-19 vaccines. 

Download Attachment

See all Member News